"Research Centers of America contributes to the development of new medications and brings new treatments to our community. We are an independently owned and operated research company in South Florida. RCA’s highly experienced staff has conducted over 1,000 clinical research trials. Our research studies provide pharmaceutical companies with valid and useful data to discover better treatment options for the future. RCA’s mission is to be the best-in-class clinical research site that contributes to the medical field by conducting research trials at the highest ethical standards. We are committed to finding workable treatments to provide a better future."

During the past decade, CenExel RCA conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CenExel RCA" are "Pneumococcal Vaccines" (2 trials), "Cytomegalovirus" (1 trials), "Healthy Participants" (1 trials), "Influenza, Human" (1 trials) and "Respiratory Syncytial Virus" (1 trials). Many other conditions were trialed in "CenExel RCA" in a lesser frequency.

Most popular intervention types in "CenExel RCA" are "Biological" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "20 valent pneumococcal conjugate vaccine" (1 trials), "24 valent pneumococcal conjugate vaccine" (1 trials), "24-Valent Pneumococcal Conjugate Vaccine" (1 trials), "Active Comparator: Licensed IIV IIV will be administered as a single dose intramuscularly on Day 1" (1 trials) and "Experimental: IIV-A Investigational IIV-A will be administered as a single dose intramuscularly on Day 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "CenExel RCA" are 5 trials for "All" genders.

Currently, there are NaN active trials in "CenExel RCA". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CenExel RCA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CenExel RCA, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".